CRC has an immunosuppressive TME which stops the development of a highly effective response to ICB therapies. There exists Therefore an urgent have to determine the methods reprogram this suppressive TME in an effort to boost immunotherapy efficacy. In the current study, we made use of CRISPR KO screens to https://xp-5944320.blogginaway.com/29115264/detailed-notes-on-as1842856